RECRUITING

Safer Aging With Diabetes Monitoring

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Older adults with type 2 diabetes are at higher risk for severe hypoglycemia and its related complications (including hospitalization and death) when taking insulin. This study proposes to evaluate, in a randomized clinical trial, a strategy of safe insulin prescribing based on an educational program that leverages continuous glucose monitoring to support older adults at high risk for hypoglycemia. If the aims of this project are achieved, this novel care strategy could be widely applied to reduce severe hypoglycemia episodes in older, high-risk adults with type 2 diabetes.

Official Title

Pragmatic Clinical Trial of Continuous Glucose Monitoring-based Interventions for Safe Insulin Use in High-Risk Older Adults With Type 2 Diabetes

Quick Facts

Study Start:2024-05-01
Study Completion:2028-01-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06296485

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:75 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Age 75 years and older
  2. * Diagnosis of Type 2 Diabetes
  3. * Current treatment with insulin
  4. * Increased hypoglycemia risk (prior year hypoglycemia by self-report or utilization)
  5. * Able to communicate in English
  6. * Able to access email and the Internet
  1. * On renal dialysis
  2. * Dementia
  3. * Pacemaker or Automatic Implantable Cardioverter Defibrillator
  4. * Using insulin pump
  5. * Severe Mental Illness
  6. * Severe Visual Impairment
  7. * In Hospice
  8. * Current or recent CGM use

Contacts and Locations

Study Contact

Carolina Gonzalez
CONTACT
866-206-2969
Susana.C.Gonzalez@kp.org
Nancy W Charvat-Aguilar
CONTACT
nancy.x.charvat-aguilar@kp.org

Principal Investigator

Richard W Grant, MD MPH
PRINCIPAL_INVESTIGATOR
Kaiser Permanente Northern California - Division of Research

Study Locations (Sites)

Kaiser Permanente Fremont
Fremont, California, 94538
United States
Kaiser Permanente San Leandro
San Leandro, California, 94577
United States
Kaiser Permanente - Union City
Union City, California, 94587
United States

Collaborators and Investigators

Sponsor: Kaiser Permanente

  • Richard W Grant, MD MPH, PRINCIPAL_INVESTIGATOR, Kaiser Permanente Northern California - Division of Research

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-05-01
Study Completion Date2028-01-31

Study Record Updates

Study Start Date2024-05-01
Study Completion Date2028-01-31

Terms related to this study

Keywords Provided by Researchers

  • Hypoglycemia
  • Diabetes Education
  • Continuous Glucose Monitor

Additional Relevant MeSH Terms

  • Diabetes Mellitus, Type 2
  • Hypoglycemia